omega-n-methylarginine has been researched along with Symptom Cluster in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, W; Cunningham, JN; Damiani, P; Henderson, JL; Horovitz, JH; Rogers, D; Siconolfi, A; Statman, R | 1 |
1 other study(ies) available for omega-n-methylarginine and Symptom Cluster
| Article | Year |
|---|---|
Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation.
Topics: Animals; Arginine; Blood Pressure; Cardiac Output; Dogs; Endotoxins; Escherichia coli Infections; Hemodynamics; Nitric Oxide; omega-N-Methylarginine; Oxygen Consumption; Syndrome; Vascular Resistance | 1994 |